Abilify (aripiprazole) is a prescription atypical antipsychotic that treats depression, schizophrenia, bipolar disorder, irritability related to autism, and specific Tourette's symptoms. While most ...

Thousands of people who blame the makers of Abilify for upending their lives due to the drug’s compulsive gambling side effects will have their cases heard by the federal court in Pensacola, Florida. ...

Settlement Approval Hearings Scheduled in Ontario and Québec for December 20, 2024 and January 8, 2025 and Certification of Ontario Action This notice was approved by the Ontario Superior Court of ...

The Food and Drug Administration (FDA) issued a first-of-its-kind approval on Monday, approving the first drug in the United States with a digital ingestion tracking system. The new pill, called ...

Otsuka has finally lost its battle with the FDA to prevent generics of its antipsychotic Abilify from hitting the market. A federal judge issued a final ruling against the Japanese drugmaker, a little ...

TALLAHASSEE, Fla. – Attorney General Pam Bondi joined 42 other attorneys general Thursday to announce a $19.5 million settlement reached with Bristol-Myers Squibb Company. The settlement relates to ...

Bristol-Myers Squibb ($BMY) took a top-line hit in 2014, but that's mostly because it sold its share of a diabetes alliance to partner AstraZeneca ($AZN). This year ...